Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease: An individual participant data meta-analysis.
- DOI
- 10.1097/mcg.0000000000002228
- Published
- 2025 Aug 6
- Container
- Journal of clinical gastroenterology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/mcg.0000000000002228,
title = {Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease: An individual participant data meta-analysis.},
author = {Cummings F and Smith PJ and Fumery M and Rahmany S and Subramanian S and Kwon B and Park S and Lee YN and Buisson A},
year = {2025},
journal = {Journal of clinical gastroenterology},
doi = {10.1097/mcg.0000000000002228},
url = {https://doi.org/10.1097/mcg.0000000000002228}
}RIS
TY - JOUR TI - Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease: An individual participant data meta-analysis. AU - Cummings F AU - Smith PJ AU - Fumery M AU - Rahmany S AU - Subramanian S AU - Kwon B AU - Park S AU - Lee YN AU - Buisson A PY - 2025 JO - Journal of clinical gastroenterology DO - 10.1097/mcg.0000000000002228 UR - https://doi.org/10.1097/mcg.0000000000002228 ER -
APA
F, C., PJ, S., M, F., S, R., S, S., B, K., S, P., YN, L., & A, B. (2025). Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease: An individual participant data meta-analysis.. Journal of clinical gastroenterology. https://doi.org/10.1097/mcg.0000000000002228
Source records
- pubmed · retrieved 2026-09-26T19:22:33.365Z